MISSION Therapeutics is based in Cambridge, UK. It has raised $114M in total funding. Latest round: Series A.
MISSION Therapeutics is based in Cambridge, UK. MISSION Therapeutics has raised $114M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in October 2025. The round record for MISSION Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Pfizer Venture Investments, Sofinnova Partners, Imperial Innovations, SR One, Roche Venture Fund. 5 distinct backers are named across the disclosed rounds.
Every MISSION Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Cambridge at a similar stage.
Company funding database · Investor directory · Founder database · Mega-rounds 2026